How Modeling & Simulation is Addressing the Immunogenicity Challenge: An academic nicety is now a drug development and regulatory differentiator
Learn how modeling and simulation can help drug developers overcome the immunogenicity challenge, a major…
Piet van der Graaf and Andrzej KierzekJanuary 30, 2023
